Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Helminthiasis
Symptoms, Doctors, Treatments, Advances & More
Overview
Find a Doctor
Latest Advances
Clinical Trials
Condition 101
About Helminthiasis
What are the alternative names for Helminthiasis?
Intestinal helminthiasis
Worm infections
Top Global Doctors
For Helminthiasis
Bookmark
Click to see options
JK
Elite
Joseph Kamgno
Yaounde, CE, CM
Bookmark
Click to see options
HG
Elite
Hector H. Garcia
Lima, PE
Bookmark
Click to see options
GW
Elite
Gary J. Weil
Infectious Disease
Internal Medicine
Saint Louis, MO
Bookmark
Click to see options
GV
Elite
Govert J. Van Dam
Leiden, ZH, NL
Bookmark
Click to see options
JU
Elite
Jurg Utzinger
Basel, BS, CH
Bookmark
Click to see options
TN
Elite
Thomas B. Nutman
Allergy and Immunology
Internal Medicine
Bethesda, MD
Latest Advances
On Helminthiasis
Condition:
Biliopleural Fistulas
Journal:
Cirugia y cirujanos
Treatment Used:
Endoscopic Retrograde Cholangiopancreatography (ERCP)
Number of Patients:
8
Published —
January 26, 2021
This study evaluated the use of endoscopic retrograde cholangiopancreatography (procedure to diagnose and treat problems in the liver, gallbladder, bile ducts, and pancreas; ERCP) for the treatment of biliopleural fistulas (rare communication between the biliary system and the pleural space).
Condition:
Hepatic Hydatid Cysts
Journal:
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
Treatment Used:
Surgical Resection and Albendazole
Number of Patients:
1
Published —
January 26, 2021
The study researched the outcomes of surgical resection combined with albendazole for treating hepatic hydatid cysts.
Clinical Trials
For Helminthiasis
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 4
Intervention Type:
Drug
Participants:
300
Start Date:
October 21, 2021
A Phase IV, Multi-center, Open-label Study to Determine the Safety, Tolerability and Clinical Outcomes Following Oral Administration of EGATEN™ (Triclabendazole) in Patients (6 Years of Age or Older) With Fascioliasis.
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
18
Start Date:
April 1, 2021
An Open-label Non-randomized Phase IIa Trial to Evaluate Safety of Early Intervention in Asymptomatic Subarachnoid Neurocysticercosis